US clinical specialists to decide on Pfizer COVID-19 supporters Kumar Jeetendra | September 17, 2021 US medical experts will be meeting on Friday to debate and vote on the controversial question of giving out booster doses of Pfizer’s COVID-19 vaccine to the general population. President Joe Biden’s administration announced in August a plan to roll out third shots to everyone, not just the immune compromised already able to receive them, starting …
Coronavirus vaccines gave by India recently for UN peacekeepers depleted : UN spokesperson Kumar Jeetendra | September 18, 2021 The stock of COVID-19 vaccines donated by India earlier this year for UN peacekeepers has been exhausted, a spokesperson for UN Secretary-General Antonio Guterres said. Stphane Dujarric, Spokesman for the Secretary-General, said at the daily press briefing on Friday that the UN received a donation of 3,00,000 doses of COVID-19 vaccine from the Government of …
Researchers move forward in the development of microbial fuel cells Kumar Jeetendra | September 18, 2021 A UCLA-led group of engineers and chemists have taken an important step in the creation of fuel cells made by microbial organisms which is a method that makes use of natural bacteria to pull electrons out of organic material within the water to create electrical currents. A research paper detailing the groundbreaking technology was published …
Compact 4-Position High Pressure Benchtop Reactor Kumar Jeetendra | September 18, 2021 The Quadracell 4-position high pressure reactor from Asynt is a new synthetic tool for scientists seeking the convenience of routine parallel pressure chemistry in a compact footprint. Designed and manufactured in the UK, the robust Quadracell reactor is simple to set up and to operate, with heating and agitation provided by a standard magnetic hotplate …
Biotium Debuts Novel Fluorescent Dyes that Push Emission Further into the Infrared Spectrum Kumar Jeetendra | September 20, 2021 Fremont, CA, September 20, 2021 — Biotium, a leading supplier and inventor of fluorescent probes for life science research, announces the release of infrared CF®850 and CF®870 dyes. These novel long wavelength dyes are the first commercially available fluorescent dyes with emission maxima greater than 850 nm, allowing researchers to further investigate the “final frontier” …
Takara Bio Europe AB and Boston IVF Fertility Center Announce Partnership to Enable the Derivation of Clinical-grade hES cell lines for Cell Therapy Applications Kumar Jeetendra | September 20, 2021 September 20, 2021 –– Takara Bio Europe AB (TBEAB) is proud to officially announce a partnership with the Boston IVF Fertility Center (Boston IVF) headquartered in Waltham, Massachusetts, USA. This partnership gives TBEAB access to discarded starting material for the derivation of clinical-grade hES cell lines for cell therapy research. “When we set off to …
HealthCube and Karkinos Healthcare rolled out cancer screening camp for women in Chikkaballapur Kumar Jeetendra | September 20, 2021 Bangalore, 20th September 2021: HealthCube, a diagnostics solution provider with the vision of transforming healthcare through the delivery of point-of-care diagnostics, has set-up cancer screening camps in Chikkaballapur, Karnataka to test for early signs/symptoms of the four major cancers, breast, oral, cervical and colorectal. The screening across the 6 taluks will be in accordance with …
New Cryopreservation Excipient Helps Accelerate Cell Therapy Product Development Kumar Jeetendra | September 21, 2021 AMSBIO has launched STEM-CELLBANKER® EX – a next generation cryopreservation product that eliminates the need for the traditional washing steps required in cell therapy product development. Rapid developments in cell, tissue, and gene therapies over the last decade have redefined what a cell therapy can be. The use of living cells as the active medicinal …
India govt will not accepting Pfizer, Moderna vaccines in the midst of nearby yield: Report Kumar Jeetendra | September 21, 2021 India’s government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccines has jumped. That essentially means the globally popular vaccines, which their makers have pledged not to sell to private parties during the pandemic, will not be available for now in the …
UK starts trial of multivariant COVID-19 vaccine booster Kumar Jeetendra | September 21, 2021 A phase one trial of a multivariant COVID-19 vaccine booster drug has got underway among participants aged over 60 in the UK. The trial, involving GRT-R910, has been launched by US pharmaceutical company Gritstone in collaboration with the University of Manchester and Manchester University NHS Foundation Trust. It will explore the potential of the drug …
Glenmark receives USFDA approval to market generic anti-biotic cream Kumar Jeetendra | September 22, 2021 Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market Clindamycin Phosphate Foam, an antibiotic used for treating bacterial infections, in the American market. The Mumbai-based firm has received final approval from the US Food and Drug Administration (USFDA) to market Clindamycin Phosphate Foam (1 per cent) which is …
WHO announces a global decrease in COVID-19 cases that are new Kumar Jeetendra | September 22, 2021 The number of new COVID-19 cases continued to fall last week, with 3.6 million new cases reported globally, down from 4 million new infections the previous week, the World Health Organization said. Last week’s drop marked the first substantial decline for more than two months, with falling COVID-19 cases in every world region. In its …
